TCMBANKIN037130 |
calycosin b |
|
C18H14O8 |
|
COC1=C(C(=C(C=C1)C2=C(C3=C(C4=C(C=C3O2)OCO4)O)C=O)OC)O |
TCMBANKIN037389 |
Calycosin C |
|
|
|
|
TCMBANKIN038032 |
formononetin |
Oprea1_815287; AIDS027672; 7-hydroxy-3-(4-methoxyphenyl)-4H-benzopyran-4-one; Isoflavone, 7-hydroxy-4'-methoxy- (8CI); NCI60_042081; NCGC00095207-03; Oprea1_139748; NCIOpen2_005983; SDCCGMLS-0066428.P001; CHEBI:18088; TNP00176; 485-72-3; Formononetol; Isoflavone, 7-hydroxy-4'-methoxy-; 7-hydroxy-3-(4-methoxyphenyl)chromone; Spectrum2_000560; Formononetin; NSC 93360; EINECS 207-623-9; 47752_FLUKA; KBio2_000853; 7-Hydroxy-3-(4-methoxyphenyl)-4-benzopyrone; Spectrum5_000258; KBio3_001519; NSC93360; KBioSS_000853; Spectrum_000373; SPECTRUM102007; KBio2_005989; Biochanin B; KBioGR_001878; NCGC00017269-01; 7-Hydroxy-3-(4′-methoxyphenyl)-4H-benzopyran-4-one; formononetin ; 7-hydroxy-4'-methoxy-isoflavone; BSPBio_002299; ZINC00113304; 4H-1-Benzopyran-4-one, 7-hydroxy-3-(4-methoxyphenyl)- (9CI); SBB016445; Spectrum3_000660; 7-hydroxy-3-(4-methoxyphenyl)-4H-chromen-4-one; Spectrum4_001429; DivK1c_006319; KBio2_003421; SPBio_000639; NCGC00095207-01; KBio1_001263; AIDS-027672; 7-Hydroxy-4'-methoxyisoflavone; C00858; 4H-1-Benzopyran-4-one, 7-hydroxy-3-(4-methoxyphenyl)-; NCGC00095207-02; SpecPlus_000223 |
C16H12O4 |
268.264 |
C1([H])=C(c2c([H])c([H])c(OC([H])([H])[H])c([H])c2[H])C(c3c(O1)c([H])c(O[H])c([H])c3[H])=O |
TCMBANKIN041338 |
3'-o-trans-cinnamoyl-astilbin |
|
C30H28O12 |
|
CC1C(C(C(C(O1)OC2C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC(=C(C=C4)O)O)O)OC(=O)C=CC5=CC=CC=C5)O |
TCMBANKIN046173 |
alpha-Maackiain-mono-beta-D-glucoside |
|
C22H22O10 |
446.404 |
c12c(c([H])c(O[C@]([H])(c(c([H])c([H])c(O[C@@]3([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O3)c4[H])c4OC5([H])[H])[C@]56[H])c6c1[H])OC([H])([H])O2 |
TCMBANKIN046238 |
Calycosin A |
|
|
|
|
TCMBANKIN046340 |
maackiain |
DivK1c_006653; ACon1_001470; KBio2_005854; KBio2_000718; {6H-[1,3]Dioxolo[5,6]benzofuro[3,} {2-c][1]benzopyran-3-ol,6a,12a-dihydro-,} (6aR-cis)- (CA INDEX NAME); MolPort-001-741-842; 6H-[1,6]benzofuro[3,2-c][1]benzopyran-3-ol,6a,12a-dihydro-, (6aR-cis)- (CA INDEX NAME); Maackiain; AC1Q70VW; AC1L7NNG; BSPBio_001901; I14-33926; 6a,12a-Dihydro-6H-(1,3)dioxolo(5,6)benzofuro(3,2-c)(1)benzopyran-3-ol; Y0131; 19908-48-6; NP-005240; cis-6a,12a-Dihydro-6H-[1,3]dioxolo[4',5':5,6]benzofuro[3,2-c]chromen-3-ol; SCHEMBL12810278; MCULE-6921694418; KBioSS_000718; 4CN-0700; KBio2_003286; CHEMBL239047; BRD-A95445494-001-03-7; SpecPlus_000557; KBio1_001597; 6a,12a-Dihydro-6H-[1,3]dioxolo[4',5':5,6][1]benzofuro[3,2-c]chromen-3-ol; Spectrum_000238; NCGC00095514-02; SPECTRUM201654; NSC-629152; Spectrum4_001528; FT-0689334; 3-hydroxy-8,9-methylenedioxypterocarpane; NCGC00095514-01; KBioGR_001936; Spectrum2_001925; Spectrum5_000036; SPBio_001929; AKOS015909127; KBio3_001401; NSC629152; 6a,12a-Dihydro-6H-[1,3]dioxolo[5,6]benzofuro[3,2-c][1]benzopyran-3-ol; CCG-38492; 6a,12a-Dihydro-6H-(1,3)dioxolo(5,6)benzofuro(3,2-c)chromen-3-ol; CHEBI:73029; HUKSJTUUSUGIDC-UHFFFAOYSA-N; 6a,12a-Dihydro-6H-[1,3]dioxolo[4',5':5,6][1]benzofuro[3,2-c]chromen-3-ol #; 5,7,11,19-TETRAOXAPENTACYCLO[10.8.0.0(2),(1)?.0?,?.0(1)(3),(1)?]ICOSA-2(10),3,8,13(18),14,16-HEXAEN-16-OL; Spectrum3_000231; MFCD02113824; NCGC00095514-04!; 6a,12a-dihydro-6H-[1,3]dioxolo[5,6][1]benzofuro[3,2-c]chromen-3-ol; NCGC00095514-03 |
C16H12O5 |
284.26 g/mol |
C1C2C(C3=C(O1)C=C(C=C3)O)OC4=CC5=C(C=C24)OCO5 |
TCMBANKIN049443 |
astilbin |
4H-1-Benzopyran-4-one, 3-((6-deoxy-alpha-L-mannopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-, (2R,3R)-; (2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-chroman-4-one; Isoastilbin; (2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-3,4-dihydro-2H-chromen-3-yl 6-deoxy-alpha-L-mannopyranoside; (2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-2-tetrahydropyranyl]oxy]-4-chromanone; astilbin ; (2R-trans)-3-((6-Deoxy-alpha-L-mannopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-4H-1-benzopyran-4-one; 4H-1-Benzopyran-4-one, 3-((6-deoxy-alpha-L-mannopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-, (2R-trans)-; MEGxp0_000363; CHEBI:38200; ACon1_000616; Neoisoastilbin; (2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychroman-4-one; (2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxy-chroman-4-one |
C21H22O11 |
450.39 |
CC1C(C(C(C(O1)OC2C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC(=C(C=C4)O)O)O)O)O |
TCMBANKIN061496 |
calycosin |
HSDB 8109; 7-hydroxy-3-(3-hydroxy-4-methoxyphenyl)chromen-4-one; CHEBI:17793; 7-hydroxy-3-(3-hydroxy-4-methoxyphenyl)-4H-chromen-4-one; 09N3E8P7TA; calycosin (OLD); 20575-57-9; HY-N0519; ZINC6018563; 7-hydroxy-3-(3-hydroxy-4-methoxyphenyl)-1-benzopyran-4-one; 3'-hydroxy-formononetin; calycosin ; LMPK12050056; MEGxp0_001325; BRD-K05039497-001-01-6; 7-hydroxy-3-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one; 3',7-dihydroxy-4'-methoxy-isoflavone; AKOS015896719; UNII-09N3E8P7TA; 4H-1-Benzopyran-4-one, 7-hydroxy-3-(3-hydroxy-4-methoxyphenyl)-; 3', 7-dihydroxy-4'-methoxyisoflavone; 575C579; C01562; HMS2268B05; C-17889; MolPort-001-741-659; Calycosin; X1103; SCHEMBL73013; Q-100254; AC1NQX1G; 7-hydroxy-3-(3-hydroxy-4-methoxy-phenyl)chromen-4-one; 7-hydroxy-3-(3-hydroxy-4-methoxyphenyl)-4-chromenone; 7-hydroxy-3-(3-hydroxy-4-methoxy-phenyl)chromone; CHEMBL241608; CS-3715; ZZAJQOPSWWVMBI-UHFFFAOYSA-N; BG01576591; MLS000876988; DTXSID70174580; 3',7-dihydroxy-4'-methoxyisoflavone; ACon1_000650; I07-0176; NP-004576; NCGC00169494-01; 3-(4-methoxy-3-oxidanyl-phenyl)-7-oxidanyl-chromen-4-one; MCULE-7559555984; 7,3'-dihydroxy-4'-methoxyisoflavone; A814711; N1412; 3'-hydroxyformononetin; FT-0630465; MFCD00210598; SMR000440659; AN-8397; AC-8043; 3',7-dihydroxy-4'-methoxy-isoflavone |
C16H12O5 |
284.26 g/mol |
COC1=C(C=C(C=C1)C2=COC3=C(C2=O)C=CC(=C3)O)O |
TCMBANKIN061844 |
afrormosin |
SMR001397241; ZINC6018480; MolPort-009-755-018; HMS2198K16; NCGC00247474-01; 6-Methoxyformonetin; Castanin; CHEMBL464404;Castanin; MLS002473149; ST50331738; Isoflavone, 7-hydroxy-4',6-dimethoxy-; MCULE-7064090251; CHEBI:2506; 4H-1-Benzopyran-4-one, 7-hydroxy-3-(4-methoxyphenyl)-6-methoxy-; BDBM50241529; LMPK12050100; C10199; 550-79-8; 6,4'-Dimethoxy-7-hydroxyisoflavone; 7-hydroxy-6-methoxy-3-(4-methoxyphenyl)chromen-4-one; DTXSID90203543; ST095421; 4H-1-Benzopyran-4-one, 7-hydroxy-6-methoxy-3-(4-methoxyphenyl)-; KJGPBYUQZLUKLL-UHFFFAOYSA-N; Afrormosine; cid_5281704; 7-hydroxy-6-methoxy-3-(4-methoxyphenyl)-chromen-4-one; Afrormosin; 7-hydroxy-6-methoxy-3-(4-methoxyphenyl)-4H-chromen-4-one; 7-hydroxy-6-methoxy-3-(4-methoxyphenyl)-4H-1-benzopyran-4-one; AKOS024286653; AC1NQYXM; SCHEMBL572274; Afromosin |
C17H14O5 |
298.29 g/mol |
COC1=CC=C(C=C1)C2=COC3=CC(=C(C=C3C2=O)OC)O |
TCMBANKIN061885 |
(?)-medicarpin |
|
|
270.28 g/mol |
COC1=CC2=C(C=C1)C3COC4=C(C3O2)C=CC(=C4)O |
TCMBANKIN061887 |
medicarpin-3-o-glucoside |
(2S,3R,4S,5S,6R)-2-[[(6aR,11aR)-9-methoxy-6a,11a-dihydro-6H-benzofurano[3,2-c]chromen-3-yl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; Medicarpin 3-O-glucoside; C16223; (2S,3R,4S,5S,6R)-2-[[(6aR,11aR)-9-methoxy-6a,11a-dihydro-6H-benzofurano[3,2-c]chromen-3-yl]oxy]-6-methylol-tetrahydropyran-3,4,5-triol; (2S,3R,4S,5S,6R)-2-[[(6aR,11aR)-9-methoxy-6a,11a-dihydro-6H-[1]benzoxolo[3,2-c]chromen-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol |
C22H24O9 |
432.4 g/mol |
COC1=CC2=C(C=C1)C3COC4=C(C3O2)C=CC(=C4)OC5C(C(C(C(O5)CO)O)O)O |